E

Controversies in the Predictive Value of PD-L1 for Anti-PD-1 Benefit in Metastatic Gastroesophageal Cancer

By Elizabeth Smyth FEATURING Raghav Sundar
220 views
April 26, 2024
0 Comments
Login to view comments. Click here to Login

Featured Video

15:07
Exelixis

Safety and Efficacy Data of a TKI Monotherapy in HCC

Feat. J. Mizrahi

Featured Video

10:25
Exelixis

Explore the mechanism of Action of a TKI in HCC

Feat. W. Keiser

Related Content

AUTOPLAY
27:37
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Expert Panel Discussion: Practice-Changing Updates

Feat. N. Uboha, A. Turk, K. Spencer, M. Cecchini
23:58
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Key Studies

Feat. R. Kim, R. Mehta
29:25
Young Chae

Hyperprogression in Cancer Treated With Immunotherapy

27:12
Moffitt Cancer Center

Year in Review: Upper GI Cancers

Feat. R. Kim, R. Mehta
13:47
Aditya Shreenivas

Neoadjuvant IO in MSI-High GI Cancers: Special Focus on the DREAM GI…

Feat. S. Chakrabarti
07:35
Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Summary: "Gastro-Esophageal Key Studies Including…

Feat. R. Kim, R. Mehta
09:42
Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Panel Discussion: "MATTERHORN & KEYNOTE-585 C…

Feat. Y. Janjigian, S. Cytryn, S. Klempner
23:27
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "GI Key Studies Including MATTERHORN & K…

Feat. R. Kim, R. Mehta
17:23
Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Summary: "Esophageal Squamous Cell Carcinoma Key …

Feat. R. Kim, R. Mehta
23:26
Yale Cancer Center

GI Cancer Updates: The Role of Surgery After Neoadjuvant Systemic Th…

Feat. C. Balch
18:51
Hope for Stomach Cancer

1L Therapy for Stage 4 Gastroesophageal Cancers: The Role of Biomark…

Feat. D. Catenacci
10:23
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Randomized Phase 3 GASTFOX Study - 5-fluor…

Feat. A. Zaanan
06:53
Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Panel Discussion: "SKYSCRAPER-08 Clinical Implica…

Feat. Y. Janjigian, S. Cytryn, S. Klempner
04:18
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Biomarker Analysis of 2 Zolbetuximab Phas…

Feat. K. Shitara
03:31
ecancer

ESMO 2023 Summary: "Highlights From Recent GI Cancer Trials&quo…

Feat. B. Gyawali
06:39
Oncology Data Advisor

Additional Advances in Esophagogastric Cancer Research and Clinical …

Feat. J. Ajani
08:35
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Phase 3 ATTRACTION-5 Study - Nivo + Chemo…

Feat. M. Terashima
20:44
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Panel Discussion: "Upper GI Cancers"

Feat. S. Cytryn, F. Pietrantonio, G. Argiles Martinez
04:01
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "3Yr Follow-Up of RATIONALE-306 - Tisleliz…

Feat. H. Yoon
15:47
Integrity Continuing Education

Resectable GEJ Adenocarcinoma: Case Presentation and Expert Panel Di…

Feat. K. Bever, R. Voong, J. Hernandez, S. Klempner